Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Aqua Bio Technology Share Issue/Capital Change 2026

Feb 27, 2026

3535_rns_2026-02-27_b064486e-1a21-4b08-a701-650abcc1ea4e.html

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

Aqua Bio Technology ASA: Ex. share consolidation and change of ISIN today

Aqua Bio Technology ASA: Ex. share consolidation and change of ISIN today

Reference is made to the key information notice on 25 February 2026 published

by Aqua Bio Technology ASA (the "Company"). The shares of the Company are

trading exclusive the share consolidation (reverse share split) as of today,

as described below.

Issuer name: Aqua Bio Technology ASA

Ex-date: 27 February 2026

Type of corporate action: Share consolidation (reverse share split)

Reverse split ratio: 50:1, i.e. fifty (50) old shares give one (1) new share.

Other information: Following completion of the share consolidation, the new

number of issued shares of the Company will be 3,227,935 shares, each with a

par value of NOK 5.00.

New ISIN: NO 001 3735894

Contacts

Kristian Flaten

CEO & CFO

Aqua Bio Technology ASA

Phone: +47 9509 2322

Email: [email protected]

About Us

Aqua Bio Technology ASA (ABTEC) is a technology and distribution group in

skincare and nonfood. The group has distribution towards B2C and B2B, and

offers freight, customs, and logistics services. The group also develops

sustainable biotechnology for use in skincare products. Aqua Bio Technology is

listed on Euronext Expand Oslo.

This notice is published by Kristian Flaten on the listed date and time.

This information has been submitted pursuant to the Securities Trading Act §

5-12 and MAR Article 17. The information was submitted for publication,

through the agency of the contact persons set out above, at 2026-02-27 07:40

CET.